Barclays Maintains Overweight on Camtek, Raises Price Target to $185

Benzinga Newsdesk www.benzinga.com Positive 66.5%

Neg 0% Neu 0% Pos 66.5%

Barclays analyst Tom O'Malley maintains Camtek (NASDAQ:CAMT) with a Overweight and raises the price target from $175 to $185.